Karin Wåhlander
Karin Wåhlander publishes mostly in Cardiology and Cardiovascular Medicine, Hematology and Internal Medicine, on topics such as Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management and Blood Coagulation and Thrombosis Mechanisms.
- World rank
- #1,595,646 of 7,710,434 ranked researchers
- Rank in Sweden
- #20,634 of 71,437
- Works
- 47
- Citations
- 2k
- Citations per work
- 42.9
What does Karin Wåhlander research?
Karin Wåhlander's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (5%), Neuroscience (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3062.8%
- Medicine3062.8%
- Everything else1328.1%
- Life Sciences49.1%
- 1Cardiology and Cardiovascular Medicine31% of their works
- 2Hematology14% of their works
- 3Internal Medicine13% of their works
- 4Molecular Biology5% of their works
- 5Surgery5% of their works
- 6Cellular and Molecular Neuroscience4% of their works
Research topics
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Blood Coagulation and Thrombosis Mechanisms
- Antiplatelet Therapy and Cardiovascular Diseases
- Pancreatic function and diabetes
- Protease and Inhibitor Mechanisms
- Blood properties and coagulation
- Vitamin K Research Studies
Which keywords describe Karin Wåhlander's research?
The keywords of their largest research topics: Antithrombotic Therapy, Anticoagulant Therapy, Atrial Fibrillation, Hemostasis, Pulmonary Embolism, Venous Thromboembolism, Protease-Activated Receptors and Thrombin.
- Vitamin K
- Tissue Inhibitors of Metalloproteinases
- Fibrinogen
- ß-Cell Dysfunction
- Clopidogrel
- Thrombin
- Venous Thromboembolism
- Hemostasis
- Anticoagulant Therapy
- Antithrombotic Therapy
- Atrial Fibrillation
- Pulmonary Embolism
- Protease-Activated Receptors
- Aspirin
- Pancreatic Islets
- Bone Health
- Matrix Metalloproteinases
- Transglutaminases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Antithrombotic Therapy302 topics
- Anticoagulant Therapy241 topic
- Atrial Fibrillation241 topic
- Hemostasis172 topics
- Pulmonary Embolism161 topic
- Venous Thromboembolism161 topic
- Protease-Activated Receptors141 topic
- Thrombin141 topic
- Aspirin61 topic
- Clopidogrel61 topic
- Pancreatic Islets41 topic
- ß-Cell Dysfunction41 topic
- Bone Health31 topic
- Fibrinogen31 topic
- Matrix Metalloproteinases31 topic
- Tissue Inhibitors of Metalloproteinases31 topic
- Transglutaminases31 topic
- Vitamin K31 topic
Where does Karin Wåhlander work?
Karin Wåhlander's main affiliation in the publication record is AstraZeneca (Sweden), Sweden.
How many publications and citations does Karin Wåhlander have?
OpenAlex counts 47 works and 2,014 citations for Karin Wåhlander, an h-index of 21, ranking #1,595,646 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Karin Wåhlander. Posts are plain text and can be reported.